Safety of carrageenan in foods.
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Foods A recent review of the toxicology of carrageenan by Tobacman (1) raised questions about the safety of carageenan-containing foods. Intact carageenan is a high molecular weight hydrocolloid (molecular weight 1.5–20 × 106). One concern has focused on the potential for degraded (low molecular weight) carageenan to be formed by acid hydrolysis in the stomach and the possibility that this material could promote cancer of the colon (1). Rats fed degraded carrageenan have been shown to develop colorectal tumors (2). Studies involving initiation with the genotoxic carcinogen azoxymethane, followed by quantitation of the number of aberrant intestinal crypts formed in response to subsequent carrageenan exposure, have also suggested that degraded carageenan has the potential to promote colon cancer in rats (3). These findings have led to degraded carrageenan being classified by the International Agency for Research on Cancer (IARC) as 2B, a possible human carcinogen, based on animal study data. Native carrageenan has been classified by IARC as 3, unclassifiable with respect to carcinogenicity in humans. In a recent paper, Taché et al (4) used a well-established and highly sensitive aberrant crypt assay to examined the potential for carrageenan to promote azoxymethane-induced colonic cancer; they found no promoting effect when a humanized gut flora was used. Because the carrageenan was administered in the drinking water, it was available for degradation in the acidic environment of the stomach. The use of normal rodent microbiologic flora produced a promoting effect of carrageenan in this model system (4), confirming positive results of previous studies, in contrast with the negative effect that occurred using humanized intestinal flora in the rat. Thus, the conclusion must be that this colon cancer-promoting effect is a rodent-specific phenomenon, requiring a rodent intestinal microbiologic flora, and that carrageenan would not promote colon cancer in humans. The concerns with regard to the induction of ulcerative colitis expressed by Tobacman (1) are also inappropriately extrapolated from animal data with regard to human risk. There have been many studies carried out with carrageenan in animals, and carrageenan has been used to induce inflammation in susceptible species and to test the anti-inflammatory properties of new candidate drugs. Although guinea pigs are very sensitive to the induction of colitis by carrageenan, primates—a more appropriate species for comparison to humans—are resistant to the induction of colitis by carrageenan. The safety of carrageenan for use in foods was confirmed at the 57th meeting of the Joint Food and Agriculture Organization of the United Nations/World Health Organization Expert Committee on Food Additives (JECFA) in Rome in June 2001 (5). The JECFA recommended an acceptable daily intake (ADI) of “not specified,” the most favorable ADI for a food additive. This recommendation was made after a review of all of the current toxicology and carcinogenicity studies on carrageenan by two world experts in this field, S. Cohen (University of Nebraska Medical Center, Omaha, NE, USA) and N. Ito (Nagoya City University Medical School, Nagoya, Japan). It included consideration of studies not cited by Tobacman (1) in her evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Review of harmful gastrointestinal effects of carrageenan in animal experiments.
Tobacman, J. K. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109983 · Cited by 370
Cited by
Bioactive compounds in seaweed: functional food applications and legislation
Holdt, S. L., & Kraan, S. (2011) · Journal of Applied Phycology · doi:10.1007/s10811-010-9632-5 · Cited by 2,135
Medicinal and pharmaceutical uses of seaweed natural products: A review
Smit, A. J. (2004) · Journal of Applied Phycology · doi:10.1023/b:japh.0000047783.36600.ef · Cited by 806
“The International Agency for Research on Cancer classified degraded carrageenan as a possible human carcinogen, but native carrageenan remains unclassifiable with respect to causing human cancers (Carthew, 2002) and it is generally regarded as safe (Tobacman, 2001).”
BackgroundHehemann, J.-H., Kelly, A. G., Pudlo, N. A., Martens, E. C., & Boraston, A. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211002109 · Cited by 338
Algal Polysaccharides, Novel Applications and Outlook
Kraan, S. (2012) · Carbohydrates - Comprehensive Studies on Glycobiology and Glycotechnology · doi:10.5772/51572 · Cited by 270
Food additive carrageenan: Part II: A critical review of carrageenan in vivo safety studies
Weiner, M. L. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.861798 · Cited by 192
“Carthew (2002) expressed concerns with this paper in a letter to the editor. Tobacman (2001) suggested that there is extensive breakdown of CGN in vivo to small-molecular-weight products (poligeenan) in the GI tract, which could be carcinogenic.”
Background
Metadata
- Authors
- Carthew, P.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-04
- Volume
- 110
- Issue
- 4
- Pages
- A176-A177
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2092994342
- Cited by
- 23
- References
- 1
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.